LATS1 (NM_004690) Human Tagged ORF Clone Lentiviral Particle

CAT#: RC223650L4V

  • LentiORF®

Lenti ORF particles, LATS1 (mGFP-tagged)-Human LATS, large tumor suppressor, homolog 1 (Drosophila) (LATS1), 200ul, >10^7 TU/mL

ORF Plasmid: DDK tGFP



Need custom lentivirus service?
Get a free quote

CNY 21,375.00


货期*
详询

规格
    • 200 ul

Product images

经常一起买 (3)
Rabbit Polyclonal Anti-LATS1 Antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00


Lenti ORF control particles of pLenti-C-mGFP-P2A-Puro, >1x10^7 TU/ml, 0.5 ml
    • 500 ul

CNY 2,950.00


One-Wash Lentivirus Titer Kit, HIV-1 p24 ELISA
    • 96 reactions

CNY 5,230.00

Specifications

Product Data
Product Name LATS1 (NM_004690) Human Tagged ORF Clone Lentiviral Particle
Synonyms WARTS; wts
Vector pLenti-C-mGFP-P2A-Puro
ACCN NM_004690
ORF Size 3390 bp
Sequence Data
The ORF insert of this clone is exactly the same as(RC223650).
OTI Disclaimer The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info
OTI Annotation This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.
Reference Data
RefSeq NM_004690.2
RefSeq Size 4756 bp
RefSeq ORF 3393 bp
Locus ID 9113
Domains UBA, pkinase
Protein Families Druggable Genome, Protein Kinase
MW 126.7 kDa
Gene Summary The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. [provided by RefSeq, Apr 2017]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.
Customer Reviews 
Loading...